IL1B

Interleukin-1 beta · P01584 · IL1B on Sugi Atlas →

46,813 patent compounds predicted against IL1B, 27,893 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1019948 SCHEMBL1019948 0.69 18/20
SCHEMBL1020677 SCHEMBL1020677 0.69 18/20
SCHEMBL1020218 SCHEMBL1020218 0.67 18/20
SCHEMBL1020097 SCHEMBL1020097 0.67 18/20
SCHEMBL1021216 SCHEMBL1021216 0.65 18/20
SCHEMBL1020257 SCHEMBL1020257 0.64 18/20
SCHEMBL1020259 SCHEMBL1020259 0.63 18/20
SCHEMBL1023079 SCHEMBL1023079 0.63 18/20
SCHEMBL1019994 SCHEMBL1019994 0.63 18/20
SCHEMBL1019477 SCHEMBL1019477 0.62 18/20
SCHEMBL1019339 SCHEMBL1019339 0.56 18/20
SCHEMBL1020208 SCHEMBL1020208 0.81 17/20
SCHEMBL1018984 SCHEMBL1018984 0.66 17/20
SCHEMBL1019225 SCHEMBL1019225 0.66 17/20
SCHEMBL1019676 SCHEMBL1019676 0.66 17/20
SCHEMBL1020307 SCHEMBL1020307 0.66 17/20
SCHEMBL1020579 SCHEMBL1020579 0.66 17/20
SCHEMBL1019555 SCHEMBL1019555 0.64 17/20
SCHEMBL1020744 SCHEMBL1020744 0.62 17/20
SCHEMBL1019240 SCHEMBL1019240 0.60 17/20

Clinical trials — most relevant to IL1B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Amantadine for COVID-19 PHASE3UNKNOWN
Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) PHASE2/PHASE3COMPLETED
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass PHASE2/PHASE3COMPLETED
Colchicine and Inflammation in Hemodialysis Patients PHASE2UNKNOWN
Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant PHASE2COMPLETED
Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone PHASE2COMPLETED
Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy PHASE1/PHASE2UNKNOWN
The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders nanUNKNOWN
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear nanUNKNOWN
Acupuncture for Reduction of Inflammation nanCOMPLETED
Role NLRP3 Inflammasome in Weight Loss Following Sleeve Gastrectomy in Morbidly Obese Patients nanUNKNOWN
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk nanWITHDRAWN
The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia nanNOT_YET_RECRUITING
Interleukin-34 in Stage I and II Periodontitis nanCOMPLETED
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions nanRECRUITING
Corticosteroid Treatment for Acute Respiratory Distress Syndrome nanCOMPLETED
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF nanNOT_YET_RECRUITING
The Association of Resistance Exercise With the Inflammasome Activation in Obesity Subjects nanUNKNOWN
The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms. nanCOMPLETED
Post-surgery Systemic Inflammation and Neuro-immune Interactions nanCOMPLETED
Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa nanCOMPLETED
Inflammatory Cytokines in GCF and Placental Tissues in Chronic Periodontitis Patients With Preterm Delivery nanCOMPLETED
Sirtuin1 in COVID19 Patients nanUNKNOWN
Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support nanUNKNOWN
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels nanRECRUITING
Early Regenerative Intervention for Post-Traumatic Osteoarthritis nanUNKNOWN
Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients nanCOMPLETED
Genetic Polymorphisms Associated With CAD nanUNKNOWN
Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer. nanUNKNOWN
Study to Evaluate the Effect of Botanical Dietary Supplements on Inflammation in Healthy People nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a IL1B binder may also engage these)

ProteinNameSimilarity
P79182 1.000 P79182 →
P46648 1.000 P46648 →
Q28386 1.000 Q28386 →
Q2HZH0 1.000 Q2HZH0 →
P21621 1.000 P21621 →
P79162 1.000 P79162 →
Q2MH07 1.000 Q2MH07 →
P09428 1.000 P09428 →
Q28292 1.000 Q28292 →
P51745 1.000 P51745 →
Q63264 1.000 Q63264 →
P51493 1.000 P51493 →
P41687 1.000 P41687 →
Q6R2X3 1.000 Q6R2X3 →
Q6PUD2 1.000 Q6PUD2 →
P14628 1.000 P14628 →
P10749 0.999 P10749 →
A4UYK8 0.999 A4UYK8 →
Q865X8 0.998 Q865X8 →
P48090 0.998 P48090 →
Q9WVG1 0.998 Q9WVG1 →
P26889 0.997 P26889 →
Q8WNR2 0.996 Q8WNR2 →
P04822 0.993 P04822 →
Q9XS77 0.991 Q9XS77 →
O46613 0.990 O46613 →
P08831 0.988 P08831 →
Q9YGD3 0.988 Q9YGD3 →
Q3HWU1 0.988 Q3HWU1 →
Q28385 0.987 Q28385 →